HEMATOPOIETIC GROWTH-FACTOR THERAPY OF MYELODYSPLASTIC SYNDROMES

被引:5
作者
ARCENAS, AG [1 ]
VADHANRAJ, S [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CLIN IMMUNOL & BIOL THERAPY,HOUSTON,TX 77030
关键词
D O I
10.3109/10428199309064264
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:65 / 69
页数:5
相关论文
共 54 条
[1]  
List A.F., Garewal H.S., Sandberg A.A., The myelodysplastic syndromes biology and implications for management, J. Clin. Oncol., 8, pp. 1424-1441, (1990)
[2]  
Heyman M.R., Recent advances in biology and treatment of myelodysplasia, Curr. Opinion Oncol., 3, pp. 44-53, (1991)
[3]  
Noel P., Salberg L.A., Myelodysplastic syndromes: pathogenesis, diagnosis and treatment, Crit. Rev. Oncol. Hematol., 12, pp. 193-215, (1992)
[4]  
Bennett J.M., Catovsky D., Daniel M.T., Et al., Proposal for the classification of the myelodysplastic syndromes, Br. J. Haematol., 51, pp. 189-199, (1982)
[5]  
Cheson B.D., The myelodysplastic syndromes. Current approaches to therapy, Ann. Intern. Med., 112, pp. 932-941, (1990)
[6]  
Noel P., Management of patients myelodysplastic syndromes, Mayo Clin. Proc., 66, pp. 485-497, (1991)
[7]  
Groopman J.E., Molina J.M., Scadden D.T., Hematopoietic growth factors: biology and clinical application, N. Engl. J. Med., 21, pp. 1449-1459, (1989)
[8]  
Broxmeyer H.E., Vadhan-Raj S., Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins, Immunol. Res., 8, pp. 185-201, (1989)
[9]  
Demitri G.D., Hematopoietic growth factors current knowledge, future prospects, Curr. Prob. Can., 16, pp. 179-259, (1992)
[10]  
Vadhan-Raj S., Broxmeyer H.E., Hittelman W.N., Use of granulocyte-macrophage colony stimulating factor in hematopoietic disorders, biology and nature of response, Semin. Hematol., 29, pp. 4-13, (1992)